AstraZeneca COVID vaccine 70% effective vs B117 variantLianna Matt McLernon | News Writer | CIDRAP NewsMar 31, 2021The vaccine was 70.4% effective against symptomatic B117 and 81.5% against other strains.https://www.cidrap.umn.edu/news/178636/rss Share on Facebook Tweet Now Follow us Share Share Share Share Share Share this:TwitterFacebookLike this:Like Loading...Related Post navigationPfizer, BioNTech: COVID vaccine effective in teens News Scan for Mar 31, 2021
